Gynecological
Ovarian, Stage III-IV Clear Cell
GOG 0268: Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Cancer
Ovarian, Primary Peritoneal, or Fallopian Tube, Recurrent
GOG 213: Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
GOG 0186-K: Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
For more information, contact
Cheryl Patz, RN, OCN, CCRC, at (360) 715-4133.
